MedTrace Logo

CATHETER ANALGESIA TRIAL Phenazopyrdine vs. Placebo: a Randomized Controlled Trial

NCT00771173 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 258

Last updated 2016-09-29

Study results available
· View outcomes & findings →

Summary

The primary aim of this randomized clinical trial is to compare the utility of phenazopyridine HCl vs. placebo in reducing catheter-associated discomfort during the post-operative period in the gynecologic patient using mean VAS measurments.

Conditions

  • Catheter-related Bladder Discomfort

Interventions

DRUG

phenazopyridine HCl

Phenazopyrdine HCl 200 mg q8h x 24

OTHER

Placebo

Placebo tablet administered q8 hours for 24 hours postop.

Sponsors & Collaborators

  • Loyola University

    lead OTHER

Principal Investigators

  • Linda Brubaker, MD · Loyola University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-08-31
Primary Completion
2010-01-31
Completion
2010-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00771173 on ClinicalTrials.gov